Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

The FDA approved a new Pfizer drug for hair loss in teens.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

PAD enzymes play a key role in hair growth and structure.

DPP may help hair regrowth by improving blood vessel function under stress.

Baricitinib is not very effective for severe alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Tofacitinib might be used to treat hair loss.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.